Read + Share
Lorenzi M, Ferro A, Cecere F, Scattolin D, et al. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung
Cancer: Outcome and Safety in the Real World: FLOWER Study. Oncologist 2022;27:87-e115.
PMID: 35641222
|
 |
|
Lorenzi M, Ferro A, Cecere F, Scattolin D, et al. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung
Cancer: Outcome and Safety in the Real World: FLOWER Study. Oncologist 2022;27:87-e115.
PMID: 35641222
|
|
|
|